56 results
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
8 Oct 24
Report of Foreign Private Issuer
8:59am
Litigation Reform Act of 1995. All statements other than statements of historical or current fact included in this press release are forward-looking
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
27 Sep 24
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
7:15am
of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
10 Sep 24
Report of Foreign Private Issuer
8:15am
, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical or current fact included in this press
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
15 Aug 24
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
8:40am
of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform
6-K
EX-99.1
yixmt3
5 Jul 24
Report of Foreign Private Issuer
7:15am
424B3
jf9ce
8 May 24
Prospectus supplement
8:32am
6-K
EX-99.1
wrz3tv 50np036uugr
7 May 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.3
1ygn72l
7 May 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
im4fuwo5a0n54pbcv
29 Apr 24
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
8:15am
6-K
EX-99.1
1eweiewivk
19 Apr 24
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
8:03am
6-K
EX-99.1
xe2t arydfn
18 Apr 24
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
8:15am
6-K
EX-99.1
pw690fzp6i4drngub8l
9 Apr 24
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
8:20am
6-K
EX-99.1
o38704pe36qb
3 Apr 24
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility
8:10am
6-K
EX-99.1
p5bpvk3i
16 Feb 24
YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting
8:25pm
6-K
EX-99.1
but up4d3
14 Feb 24
Report of Foreign Private Issuer
8:05am